CBD for Sleep: Does It Actually Work?
Cannabis & Sleep
66.7%
The largest CBD sleep study found sleep scores improved in 66.7 percent of patients during the first month, but the benefit works indirectly through anxiety reduction rather than direct sedation.
Shannon et al., The Permanente Journal, 2019
Shannon et al., The Permanente Journal, 2019
View as imageCBD is everywhere in the sleep market. Gummies, tinctures, capsules, and teas all marketed as natural sleep solutions. The narrative is simple: CBD is the calming part of cannabis, it helps you relax, and relaxation helps you sleep. Like most simple narratives about complex pharmacology, this one is partly right and mostly incomplete.
The honest answer to whether CBD works for sleep is: it depends on why you cannot sleep, what you expect it to do, what dose you take, and whether the product you are using actually contains what it claims. Understanding each of these variables is the difference between a useful tool and a waste of money.
Key Takeaways
- CBD does not knock you out the way THC does — it is not a sedative, and expecting it to work like one will leave you thinking it "does not work"
- The strongest case for CBD for sleep is actually indirect — CBD reduces anxiety, and anxiety is one of the most common causes of insomnia, so it may help you sleep by removing the barrier rather than forcing sedation
- Unlike THC, CBD does not suppress REM sleep, does not disrupt sleep architecture, does not build tolerance to its sleep effects at the same rate, and does not cause withdrawal insomnia when you stop
- The 2019 Shannon study found anxiety scores dropped in 79.2 percent of patients and sleep scores improved in 66.7 percent during the first month of CBD use, though sleep benefits fluctuated more than anxiety benefits over time
- CBD dosing for sleep is not standardized — research has used doses from 25 mg to 300 mg, and higher doses seem more sedating while lower doses may actually be mildly alerting, so finding your dose takes some trial and error
- The CBD market has serious quality control problems — independent testing shows many products contain more or less CBD than labeled, and some have undisclosed THC, so product selection matters as much as the compound itself
How CBD Interacts With Sleep Systems
CBD vs THC
CBD for Sleep: How It Compares to THC
CBD works indirectly through anxiety reduction, not direct sedation
Onset speed
REM preservation
Tolerance buildup
Withdrawal insomnia
Anxiety reduction
Direct sedation
CBD sleep pathways
Shannon (2019): 79% anxiety improved, 67% sleep improved
CBD vs THC Sleep MechanismsCBD does not work like THC when it comes to sleep. THC binds directly to CB1 receptors in the brain and produces sedation. It forces drowsiness through a specific receptor mechanism. This is why THC knocks you out — it is acting on the same neural systems that regulate wakefulness and effectively turning down the volume on wake-promoting circuits.
CBD's mechanism is different and less direct. CBD has low affinity for CB1 and CB2 receptors. Instead, it modulates several other systems that are relevant to sleep.
Serotonin system. CBD acts as an agonist at the 5-HT1A serotonin receptor. This receptor is involved in anxiety regulation, and activation reduces anxiety and promotes calmness. Since anxiety is one of the most common barriers to sleep, this anxiolytic effect is likely the primary pathway through which CBD improves sleep for many people.
Cortisol. Research has found that CBD can reduce cortisol levels. Cortisol is a stress hormone that, when elevated at night, prevents sleep onset and causes early-morning awakening. By blunting the cortisol response, CBD may reduce one of the physiological barriers to falling and staying asleep.
Endocannabinoid system modulation. CBD inhibits the FAAH enzyme that breaks down anandamide, an endogenous cannabinoid involved in mood and relaxation. By increasing available anandamide, CBD may promote a general state of physiological calm without the direct sedation that THC produces.
The practical implication is important: CBD does not knock you out. If you take CBD expecting the rapid-onset sedation that THC provides, you will be disappointed and conclude it does not work. CBD works by reducing the things that keep you awake — primarily anxiety and physiological stress — rather than by directly inducing unconsciousness.
What the Clinical Evidence Shows
The clinical evidence for CBD and sleep is growing but still limited compared to many pharmaceutical sleep interventions.
The most frequently cited study is Shannon and colleagues, published in 2019 in The Permanente Journal. This retrospective case series examined 72 adults presenting with anxiety and poor sleep at a psychiatric clinic. Patients received CBD at 25 to 175 mg per day in capsule form alongside their standard psychiatric treatment.
The results were instructive. Anxiety scores improved in 79.2% of patients during the first month and remained improved over the study period. Sleep scores improved in 66.7% of patients during the first month. However — and this is an important detail often omitted from marketing materials — sleep improvements fluctuated more over time than anxiety improvements. Some patients who initially improved on sleep measures saw the benefit diminish in subsequent months.
This pattern supports the interpretation that CBD's sleep benefit is mediated primarily through anxiety reduction. The anxiety benefit was more consistent and durable, while the sleep benefit was more variable — suggesting that when sleep problems had an anxiety component, CBD helped, and when they did not, the benefit was less reliable.
Other research is more preliminary. A 2018 review by Kuhathasan and colleagues examined existing literature on cannabinoids and sleep and concluded that CBD showed "therapeutic potential" for insomnia but that large-scale randomized controlled trials were lacking. A handful of smaller studies have shown modest improvements in subjective sleep quality, but the evidence base is not yet comparable to established sleep treatments like CBT-I or even pharmaceutical sleep aids.
The Dose-Response Paradox
One of the most confusing aspects of CBD and sleep is the biphasic dose response. CBD does not follow a simple more-is-better pattern.
Research and clinical observations suggest that lower doses of CBD (15 to 25 mg) may actually be mildly alerting rather than sedating. This is consistent with CBD's pharmacological profile — at low doses, the activating effects on certain receptor systems may predominate.
Moderate doses (25 to 75 mg) appear to provide the anxiolytic effect without significant sedation or alertness. This is the range where anxiety-related insomnia may improve the most.
Higher doses (150 to 300 mg) appear more directly sedating, though the evidence here is from a smaller number of studies and the mechanism at these doses may involve different pathways than the anxiolytic effect seen at moderate doses.
The practical problem is that most commercial CBD products are dosed at 10 to 25 mg per serving, which is at the low end of the potentially therapeutic range and within the range that some research suggests may be mildly alerting. If someone takes a 10 mg CBD gummy expecting to sleep better and finds no benefit or even increased alertness, the issue may be dose rather than efficacy.
This also means that finding your effective dose requires experimentation. Start at 25 to 50 mg taken 30 to 60 minutes before bed. If you notice no sleep benefit after 3 to 5 nights, increase by 25 mg. Continue titrating upward in 25 mg increments every 3 to 5 nights until you notice benefit or reach 150 mg. If 150 mg produces no sleep improvement, CBD is likely not addressing your specific sleep barrier.
CBD vs. THC for Sleep: A Direct Comparison
The comparison illuminates why CBD is genuinely preferable for some people and inadequate for others.
Sleep onset. THC wins decisively. If the primary problem is lying awake unable to fall asleep, THC produces faster onset of unconsciousness. CBD does not produce rapid sedation and may take 30 to 60 minutes to produce noticeable calming effects.
Sleep architecture. CBD wins decisively. THC suppresses REM sleep, disrupts stage distribution, and degrades sleep quality over time. CBD does not suppress REM, does not cause the light-sleep redistribution seen with THC, and preserves more natural sleep architecture. Sleep on CBD more closely resembles healthy sleep than sleep on THC.
Tolerance. CBD wins. THC builds tolerance to its sleep effects within weeks, requiring escalating doses. CBD does not appear to build tolerance at the same rate, and the sleep effects, when present, tend to remain more stable over time.
Dependence and withdrawal. CBD wins. THC creates physiological dependence with extended daily use, and discontinuation produces withdrawal insomnia that drives relapse. CBD does not produce dependence or withdrawal insomnia when discontinued. You can stop taking CBD without a rebound sleep disruption.
Subjective satisfaction. THC wins in the short term. People using THC for sleep typically report more dramatic and immediate results. CBD's effects are subtler, slower, and less "felt." This is why many people try CBD, find it underwhelming compared to THC, and go back to THC — even though the objective sleep quality on CBD may be better.
The bottom line: if your insomnia is primarily driven by anxiety or stress-related hyperarousal, CBD addresses the root cause without the downstream problems of THC. If your insomnia has other causes — pain, neurological conditions, entrenched behavioral patterns — CBD may be insufficient on its own.
The Product Quality Problem
Even if CBD is pharmacologically useful for your sleep issue, the product you buy may not deliver the compound as expected.
FDA testing of commercial CBD products has found that approximately 26% of products tested contained significantly less CBD than their labels claimed. Some products contained no detectable CBD at all. Others contained undisclosed THC, sometimes enough to cause intoxication and failed drug tests.
This is not a minor issue. If you take what you believe is 50 mg of CBD and the product actually contains 15 mg, you may conclude that CBD does not work for you when the reality is that you never reached a therapeutic dose.
To mitigate this, look for products with current third-party certificates of analysis (COA) from independent laboratories. The COA should verify the CBD content per serving, confirm THC levels (should be below 0.3% for legal CBD products), and screen for contaminants like heavy metals, pesticides, and residual solvents. Products that do not provide accessible COAs should be avoided.
Sublingual tinctures generally offer better bioavailability than capsules or edibles because sublingual absorption bypasses the digestive system and first-pass liver metabolism. This means more of the CBD you consume actually reaches your bloodstream. If you have tried CBD edibles without success, switching to a sublingual tincture at the same dose may produce different results simply due to better absorption.
Who CBD for Sleep Works Best For
Based on the available evidence, CBD for sleep is most likely to help people whose insomnia is driven by anxiety, stress, or general hyperarousal. If you lie in bed with racing thoughts, elevated heart rate, or a general sense of being wired, CBD's anxiolytic mechanism directly addresses these barriers. You do not need a sedative — you need something to reduce the activation that is preventing your natural sleep systems from engaging.
CBD is less likely to help people whose insomnia is driven by pain (unless it also has anti-inflammatory effects at your dose), sleep apnea, circadian rhythm disruption, or purely behavioral factors like irregular sleep schedules or stimulating environments. For these sleep barriers, CBD does not address the underlying cause.
CBD is also a reasonable option for people transitioning away from THC for sleep. Because it provides some of the relaxation benefit without the REM suppression, architecture disruption, and tolerance issues, CBD can serve as a bridge during the transition period. Some people find that switching from THC to CBD-dominant products reduces withdrawal insomnia severity while still providing enough calming effect to facilitate sleep onset. This strategy works best when combined with the behavioral interventions covered in sleep hygiene for cannabis users.
The Honest Assessment
CBD is not a miracle sleep aid. The marketing has gotten ahead of the evidence. Large-scale randomized controlled trials are lacking. The available studies are small, often uncontrolled, and frequently funded by industry.
But CBD is also not useless for sleep. The anxiolytic mechanism is well-supported, and anxiety-driven insomnia is extremely common. For the right person with the right sleep barrier, a quality CBD product at an adequate dose can meaningfully improve both sleep onset and sleep quality — and it does so without the tolerance, dependence, architecture disruption, and withdrawal problems that make THC a losing long-term sleep strategy.
The most rational approach: try it as one component of a comprehensive sleep strategy that includes sleep hygiene, consistent timing, and stress management. Do not expect it to override poor sleep habits. Use a quality product with third-party verification. Give it 2 to 3 weeks at an adequate dose before concluding whether it helps. And if your insomnia persists, pursue CBT-I, which remains the most effective long-term treatment for chronic insomnia regardless of what supplements or substances you add to it.
The Bottom Line
Evidence review of CBD for sleep covering mechanism of action, clinical evidence, comparison to THC, dosing, product quality, and practical recommendations. Mechanism: CBD does not directly sedate — it modulates serotonin (5-HT1A), reduces cortisol, and decreases anxiety/hyperarousal that prevents sleep onset. Shannon 2019 (72 adults): anxiety improved in 79.2%, sleep improved in 66.7% in first month; sleep benefits fluctuated more than anxiety benefits over time. Dose-response paradox: low doses (15-25 mg) may be mildly alerting; moderate doses (25-75 mg) anxiolytic; higher doses (150-300 mg) more sedating. CBD vs THC: no REM suppression, no sleep architecture disruption, no tolerance/dependence/withdrawal insomnia pattern. Product quality: FDA testing found 26% of products contained less CBD than labeled; some contain undisclosed THC; third-party COA essential. Practical protocol: start 25-50 mg sublingual 30-60 min before bed, titrate up over 1-2 weeks, choose products with current third-party testing. Best candidates: people whose insomnia is anxiety-driven. Poor candidates: those seeking THC-like sedation or with non-anxiety sleep barriers (sleep apnea, pain, shift work).
Frequently Asked Questions
Sources & References
- 1RTHC-00205·Rog, David J et al. (2005). “Cannabis-Based Spray Significantly Reduced MS Central Pain and Sleep Problems in Rigorous Trial.” Neurology.Study breakdown →PubMed →↩
- 2RTHC-07874·Vikingsson, Svante et al. (2025). “Legal CBD Products With Trace THC Can Cause Positive Drug Tests in Oral Fluid.” Journal of analytical toxicology.Study breakdown →PubMed →↩
- 3RTHC-07987·Xu, Carol et al. (2025). “Recreational Cannabis Laws Are Associated With People Sleeping About 5 Minutes Less.” AJPM focus.Study breakdown →PubMed →↩
- 4RTHC-07860·Velzeboer, Rob et al. (2025). “Cannabis Doesn't Consistently Change Sleep Patterns — But Withdrawal Clearly Disrupts Sleep.” Sleep medicine reviews.Study breakdown →PubMed →↩
- 5RTHC-02212·Orsolini, Laura et al. (2019). “Cannabis for PTSD in 2019: The Systematic Evidence Was Still Thin Despite Growing Interest.” Medicina (Kaunas).Study breakdown →PubMed →↩
- 6RTHC-00797·Gates, Peter J. et al. (2014). “39 Studies Later, the Evidence That Cannabis Helps You Sleep Is Weaker Than You Think.” Sleep Medicine Reviews.Study breakdown →PubMed →↩
- 7RTHC-00462·Ware, Mark A et al. (2010). “Nabilone was better than amitriptyline for improving sleep in fibromyalgia patients.” Anesthesia and analgesia.Study breakdown →PubMed →↩
- 8RTHC-00171·Nicholson, Anthony N et al. (2004). “How THC and CBD Affect Sleep: A Controlled Study with Brain Wave Monitoring.” Journal of clinical psychopharmacology.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Rog, David J · 2005
Sixty-six MS patients with central pain (59 with dysesthetic pain, 7 with painful spasms) participated in a 5-week randomized, double-blind, placebo-controlled trial of a THC:CBD oromucosal spray.
The Acute and Chronic Pharmacokinetic Oral Fluid Profile of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC) in Healthy Human Volunteers.
Vikingsson, Svante · 2025
After taking 100 mg CBD with just 0.5 mg THC (well within legal hemp limits), 1 in 10 participants tested positive for THC in oral fluid.
The Effects of Cannabis Access Laws on Sleep in the U.S.
Xu, Carol · 2025
Recreational cannabis laws reduced sleep by 5.37 minutes per night (99% CI: 0.91-9.83), primarily by delaying sleep onset by 7.14 minutes without changing wake times.
Cannabis and sleep architecture: A systematic review and meta-analysis.
Velzeboer, Rob · 2025
Across 18 studies (9 in meta-analysis), cannabis administration did not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging.
Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review
Orsolini, Laura · 2019
This systematic review gathered everything published through May 2019 on cannabis and synthetic cannabinoids for PTSD.
The effects of cannabinoid administration on sleep: a systematic review of human studies
Gates, Peter J. · 2014
Across 39 human studies that administered a cannabinoid and measured sleep quantitatively, results did not converge.
The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
Ware, Mark A · 2010
Twenty-nine fibromyalgia patients with chronic insomnia completed a crossover trial comparing nabilone (0.5-1.0 mg at bedtime) to amitriptyline (10-20 mg at bedtime), each for two weeks with a two-week washout period. Nabilone was significantly superior to amitriptyline on the Insomnia Severity Index (difference = 3.2 points, 95% CI: 1.2-5.3).
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.
Nicholson, Anthony N · 2004
In 8 healthy volunteers given sublingual cannabis extracts before sleep, 15 mg THC alone had no effect on nocturnal sleep architecture but produced next-day sedation, impaired memory, and reduced sleep latency (indicating increased sleepiness).